- Home
- KRSP vs AVIR Comparison
KRSP vs AVIR Comparison
Compare KRSP & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$5.71
Company Overview
Basic Information| Metric | KRSP | AVIR |
|---|---|---|
| Founded | 2025 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.3M | 450.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | KRSP | AVIR |
|---|---|---|
| Price | $10.30 | $5.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 12.1K | ★ 346.6K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.21 | $2.46 |
| 52 Week High | $10.70 | $6.45 |
Technical Indicators
Market Signals| Indicator | KRSP | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 48.13 | 53.63 |
| Support Level | $10.25 | $3.28 |
| Resistance Level | $10.39 | $6.37 |
| Average True Range (ATR) | 0.03 | 0.24 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 25.00 | 50.52 |
Price Performance
Historical Comparison KRSP
AVIR
About KRSP Rice Acquisition Corporation 3
Rice Acquisition Corp 3 is a blank check company.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.